Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Interventional Cardiovascular Device, Market Insights and Forecast to 2026

  • RnM4083901
  • |
  • 30 June, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Study Coverage

  • 1.1 Interventional Cardiovascular Device Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Interventional Cardiovascular Device Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Interventional Cardiovascular Device Market Size Growth Rate by Type
    • 1.4.2 Imaging System
    • 1.4.3 Catheter
    • 1.4.4 PTCA Balloon
    • 1.4.5 Stent
    • 1.4.6 PTCA Guidewire
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Interventional Cardiovascular Device Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
  • 1.6 Coronavirus Disease 2019 (Covid-19): Interventional Cardiovascular Device Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Interventional Cardiovascular Device Industry
      • 1.6.1.1 Interventional Cardiovascular Device Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Interventional Cardiovascular Device Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Interventional Cardiovascular Device Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Interventional Cardiovascular Device Market Size Estimates and Forecasts
    • 2.1.1 Global Interventional Cardiovascular Device Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Interventional Cardiovascular Device Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Interventional Cardiovascular Device Production Estimates and Forecasts 2015-2026
  • 2.2 Global Interventional Cardiovascular Device Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Interventional Cardiovascular Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Interventional Cardiovascular Device Manufacturers Geographical Distribution
  • 2.4 Key Trends for Interventional Cardiovascular Device Markets & Products
  • 2.5 Primary Interviews with Key Interventional Cardiovascular Device Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Interventional Cardiovascular Device Manufacturers by Production Capacity
    • 3.1.1 Global Top Interventional Cardiovascular Device Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Interventional Cardiovascular Device Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Interventional Cardiovascular Device Manufacturers Market Share by Production
  • 3.2 Global Top Interventional Cardiovascular Device Manufacturers by Revenue
    • 3.2.1 Global Top Interventional Cardiovascular Device Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Interventional Cardiovascular Device Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Interventional Cardiovascular Device Revenue in 2019
  • 3.3 Global Interventional Cardiovascular Device Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Interventional Cardiovascular Device Production by Regions

  • 4.1 Global Interventional Cardiovascular Device Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Interventional Cardiovascular Device Regions by Production (2015-2020)
    • 4.1.2 Global Top Interventional Cardiovascular Device Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Interventional Cardiovascular Device Production (2015-2020)
    • 4.2.2 North America Interventional Cardiovascular Device Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Interventional Cardiovascular Device Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Interventional Cardiovascular Device Production (2015-2020)
    • 4.3.2 Europe Interventional Cardiovascular Device Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Interventional Cardiovascular Device Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Interventional Cardiovascular Device Production (2015-2020)
    • 4.4.2 China Interventional Cardiovascular Device Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Interventional Cardiovascular Device Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Interventional Cardiovascular Device Production (2015-2020)
    • 4.5.2 Japan Interventional Cardiovascular Device Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Interventional Cardiovascular Device Import & Export (2015-2020)

5 Interventional Cardiovascular Device Consumption by Region

  • 5.1 Global Top Interventional Cardiovascular Device Regions by Consumption
    • 5.1.1 Global Top Interventional Cardiovascular Device Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Interventional Cardiovascular Device Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Interventional Cardiovascular Device Consumption by Application
    • 5.2.2 North America Interventional Cardiovascular Device Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Interventional Cardiovascular Device Consumption by Application
    • 5.3.2 Europe Interventional Cardiovascular Device Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Interventional Cardiovascular Device Consumption by Application
    • 5.4.2 Asia Pacific Interventional Cardiovascular Device Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Interventional Cardiovascular Device Consumption by Application
    • 5.5.2 Central & South America Interventional Cardiovascular Device Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Interventional Cardiovascular Device Consumption by Application
    • 5.6.2 Middle East and Africa Interventional Cardiovascular Device Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Interventional Cardiovascular Device Market Size by Type (2015-2020)
    • 6.1.1 Global Interventional Cardiovascular Device Production by Type (2015-2020)
    • 6.1.2 Global Interventional Cardiovascular Device Revenue by Type (2015-2020)
    • 6.1.3 Interventional Cardiovascular Device Price by Type (2015-2020)
  • 6.2 Global Interventional Cardiovascular Device Market Forecast by Type (2021-2026)
    • 6.2.1 Global Interventional Cardiovascular Device Production Forecast by Type (2021-2026)
    • 6.2.2 Global Interventional Cardiovascular Device Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Interventional Cardiovascular Device Price Forecast by Type (2021-2026)
  • 6.3 Global Interventional Cardiovascular Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Interventional Cardiovascular Device Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Interventional Cardiovascular Device Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 GE Healthcare
    • 8.1.1 GE Healthcare Corporation Information
    • 8.1.2 GE Healthcare Overview and Its Total Revenue
    • 8.1.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 GE Healthcare Product Description
    • 8.1.5 GE Healthcare Recent Development
  • 8.2 Boston Scientific
    • 8.2.1 Boston Scientific Corporation Information
    • 8.2.2 Boston Scientific Overview and Its Total Revenue
    • 8.2.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Boston Scientific Product Description
    • 8.2.5 Boston Scientific Recent Development
  • 8.3 Philips
    • 8.3.1 Philips Corporation Information
    • 8.3.2 Philips Overview and Its Total Revenue
    • 8.3.3 Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Philips Product Description
    • 8.3.5 Philips Recent Development
  • 8.4 Volcano Therapeutics
    • 8.4.1 Volcano Therapeutics Corporation Information
    • 8.4.2 Volcano Therapeutics Overview and Its Total Revenue
    • 8.4.3 Volcano Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Volcano Therapeutics Product Description
    • 8.4.5 Volcano Therapeutics Recent Development
  • 8.5 Argon Medical
    • 8.5.1 Argon Medical Corporation Information
    • 8.5.2 Argon Medical Overview and Its Total Revenue
    • 8.5.3 Argon Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Argon Medical Product Description
    • 8.5.5 Argon Medical Recent Development
  • 8.6 Spectranetics
    • 8.6.1 Spectranetics Corporation Information
    • 8.6.2 Spectranetics Overview and Its Total Revenue
    • 8.6.3 Spectranetics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Spectranetics Product Description
    • 8.6.5 Spectranetics Recent Development
  • 8.7 Angio Dynamics
    • 8.7.1 Angio Dynamics Corporation Information
    • 8.7.2 Angio Dynamics Overview and Its Total Revenue
    • 8.7.3 Angio Dynamics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Angio Dynamics Product Description
    • 8.7.5 Angio Dynamics Recent Development
  • 8.8 AccessClosure
    • 8.8.1 AccessClosure Corporation Information
    • 8.8.2 AccessClosure Overview and Its Total Revenue
    • 8.8.3 AccessClosure Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 AccessClosure Product Description
    • 8.8.5 AccessClosure Recent Development
  • 8.9 Merit Medical Systems
    • 8.9.1 Merit Medical Systems Corporation Information
    • 8.9.2 Merit Medical Systems Overview and Its Total Revenue
    • 8.9.3 Merit Medical Systems Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Merit Medical Systems Product Description
    • 8.9.5 Merit Medical Systems Recent Development
  • 8.10 B. Braun
    • 8.10.1 B. Braun Corporation Information
    • 8.10.2 B. Braun Overview and Its Total Revenue
    • 8.10.3 B. Braun Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 B. Braun Product Description
    • 8.10.5 B. Braun Recent Development
  • 8.11 C. R. Bard
    • 8.11.1 C. R. Bard Corporation Information
    • 8.11.2 C. R. Bard Overview and Its Total Revenue
    • 8.11.3 C. R. Bard Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 C. R. Bard Product Description
    • 8.11.5 C. R. Bard Recent Development
  • 8.12 Marine Polymer Technologies
    • 8.12.1 Marine Polymer Technologies Corporation Information
    • 8.12.2 Marine Polymer Technologies Overview and Its Total Revenue
    • 8.12.3 Marine Polymer Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Marine Polymer Technologies Product Description
    • 8.12.5 Marine Polymer Technologies Recent Development
  • 8.13 Cordis
    • 8.13.1 Cordis Corporation Information
    • 8.13.2 Cordis Overview and Its Total Revenue
    • 8.13.3 Cordis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Cordis Product Description
    • 8.13.5 Cordis Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Interventional Cardiovascular Device Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Interventional Cardiovascular Device Regions Forecast by Production (2021-2026)
  • 9.3 Key Interventional Cardiovascular Device Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Interventional Cardiovascular Device Consumption Forecast by Region

  • 10.1 Global Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)
  • 10.2 North America Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Interventional Cardiovascular Device Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Interventional Cardiovascular Device Sales Channels
    • 11.2.2 Interventional Cardiovascular Device Distributors
  • 11.3 Interventional Cardiovascular Device Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Interventional Cardiovascular Device Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Interventional Cardiovascular Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional Cardiovascular Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Interventional Cardiovascular Device market is segmented into
    Imaging System
    Catheter
    PTCA Balloon
    Stent
    PTCA Guidewire
    Other

    Segment by Application, the Interventional Cardiovascular Device market is segmented into
    Hospital
    Clinic

    Regional and Country-level Analysis
    The Interventional Cardiovascular Device market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Interventional Cardiovascular Device market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Interventional Cardiovascular Device Market Share Analysis

    Interventional Cardiovascular Device market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Interventional Cardiovascular Device by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Interventional Cardiovascular Device business, the date to enter into the Interventional Cardiovascular Device market, Interventional Cardiovascular Device product introduction, recent developments, etc.
    The major vendors covered:
    GE Healthcare
    Boston Scientific
    Philips
    Volcano Therapeutics
    Argon Medical
    Spectranetics
    Angio Dynamics
    AccessClosure
    Merit Medical Systems
    B. Braun
    C. R. Bard
    Marine Polymer Technologies


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Interventional Cardiovascular Device. Industry analysis & Market Report on COVID-19 Impact on Global Interventional Cardiovascular Device is a syndicated market report, published as COVID-19 Impact on Global Interventional Cardiovascular Device, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Interventional Cardiovascular Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,898.59
    5,847.89
    7,797.18
    4,334.17
    6,501.25
    8,668.34
    526,632.40
    789,948.60
    1,053,264.80
    367,434.34
    551,151.51
    734,868.68
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report